Coinbase Global Launches New A.I. Advisor

1 hour ago 4

CryptoProwl

Wed, June 17, 2026 astatine 8:03 AM CDT 1 min read

Coinbase Global Launches New A.I. Advisor

Coinbase Global Launches New A.I. Advisor

Cryptocurrency speech Coinbase Global (NASDAQ: $COIN) has launched a caller artificial quality (A.I.) advisor to assistance its clients execute trades connected its platform. 

Management said the caller A.I. advisor is portion of its efforts to physique an "everything exchange" for its idiosyncratic base.

The caller product, called "Coinbase Advisor," is described arsenic 1 of the archetypal regulatory-compliant A.I.-powered concern advisory tools disposable successful the U.S. 

More From Cryptoprowl:

  • Ripple, The Company Behind XRP, Is Valued At $50 Billion

  • Eightco Secures $125 Million Investment From Bitmine And ARK Invest, Shares Surge

  • Blockchain Projects Decline 75% As Developers Shift To A.I.

  • Stanley Druckenmiller Says Stablecoins Could Reshape Global Finance

  • New York Stock Exchange Invests $600 Million In Polymarket

Initially, the A.I. advisor is lone disposable to "Coinbase One" premium subscribers successful the U.S. 

The A.I. merchandise provides portfolio recommendations, tax-loss harvesting guidance, and marketplace investigation to assistance radical execute smarter trades, says Coinbase Global successful a statement. 

Artificial quality advisors that tin assistance investors marque informed decisions are increasing successful popularity, with immoderate analysts predicting that they volition yet marque trades autarkic of people. 

Coinbase Global CEO Brian Armstrong has said that his purpose is to crook the cryptocurrency speech into a full-service fiscal level that combines trading, payments, lending, and plus absorption into 1 platform. 

Competition is increasing arsenic exchanges determination to go a azygous destination for trading stocks, integer assets, and tokenized fiscal products from a azygous idiosyncratic account.

COIN banal has declined 33% successful the past 12 months to commercialized astatine $169.27 U.S. per share. 

Read Entire Article